Preoperative Evaluation of Thyroid Cancer: A Review of Current Best Practices.

Autor:	Russell MD; Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts. Electronic address: mrussell20@meei.harvard.edu., Shonka DC Jr; Department of Otolaryngology-Head and Neck Surgery, University of Virginia Health System, Charlottesville, Virginia., Noel J; Department of Otolaryngology-Head & Neck Surgery, Stanford University School of Medicine, Stanford, California., Karcioglu AS; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois., Ahmed AH; Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts., Angelos P; Department of Surgery, University of Chicago, Chicago, Illinois., Atkins K; Department of Pathology, University of Virginia, Charlottesville, Virginia., Bischoff L; Division of Endocrinology, Vanderbilt University Medical Center, Nashville, Tennessee., Buczek E; Department of Otolaryngology-Head and Neck Surgery, The University of Kansas Medical Center, Kansas City, Kansas., Caulley L; Department of Otolaryngology-Head and Neck Surgery, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Ontario, Canada., Freeman J; Department of Otolaryngology-Head & Neck Surgery, University of Toronto, Toronto, Ontario, Canada., Kroeker T; Texas Thyroid and Parathyroid Center, Austin, Texas., Liddy W; Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois., McIver B; Department of Head and Neck-Endocrine Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., McMullen C; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida., Nikiforov Y; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania., Orloff L; Department of Otolaryngology-Head & Neck Surgery, Stanford University School of Medicine, Stanford, California., Scharpf J; Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio., Shah J; Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Shaha A; Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Singer M; Department of Otolaryngology-Head and Neck Surgery, Henry Ford Health System, Detroit, Michigan., Tolley N; Hammersmith Hospital, Imperial College NHS Healthcare Trust, London, United Kingdom., Tuttle RM; Endocrine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Witterick I; Department of Otolaryngology-Head & Neck Surgery, University of Toronto, Toronto, Ontario, Canada., Randolph GW; Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Jazyk:	angličtina
Zdroj:	Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2023 Oct; Vol. 29 (10), pp. 811-821. Date of Electronic Publication: 2023 May 24.
DOI:	10.1016/j.eprac.2023.05.009
Abstrakt:	Objective: The incidence of thyroid cancer has significantly increased in recent decades. Although most thyroid cancers are small and carry an excellent prognosis, a subset of patients present with advanced thyroid cancer, which is associated with increased rates of morbidity and mortality. The management of thyroid cancer requires a thoughtful individualized approach to optimize oncologic outcomes and minimize morbidity associated with treatment. Because endocrinologists usually play a key role in the initial diagnosis and evaluation of thyroid cancers, a thorough understanding of the critical components of the preoperative evaluation facilitates the development of a timely and comprehensive management plan. The following review outlines considerations in the preoperative evaluation of patients with thyroid cancer. Methods: A clinical review based on current literature was generated by a multidisciplinary author panel. Results: A review of considerations in the preoperative evaluation of thyroid cancer is provided. The topic areas include initial clinical evaluation, imaging modalities, cytologic evaluation, and the evolving role of mutational testing. Special considerations in the management of advanced thyroid cancer are discussed. Conclusion: Thorough and thoughtful preoperative evaluation is critical for formulating an appropriate treatment strategy in the management of thyroid cancer. Competing Interests: Disclosure Dr Nikiforov has IP ownership and receives royalties related to Thyroseq from the University of Pittsburgh as well as Consultancy agreement with Sonic Healthcare USA. Dr Randolph has received research grants (no personal fees) from Eisai, Medtronic and Fluoptics. Dr Randolph is the program director of the Mass. Eye & Ear Infirmary Endocrine Surgery Clinical Fellowship, which receives partial funding from Medtronic. Dr Randolph is the President of the International Thyroid Oncology Group (ITOG) and the World Congress on Thyroid Cancer (WCTC), is Chair of the Administrative Division of the American Head and Neck Society (AHNS) and is the American College of Surgeons (ACS) Otolaryngology Governor. All other authors have no conflicts to disclose. (Copyright © 2023 AACE. Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu